The report covers forecast and analysis for the rheumatology therapeutics market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study includes drivers and restraints for the rheumatology therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the rheumatology therapeutics market on a global level.
This report offers comprehensive coverage of global rheumatology therapeutics market along with, market trends, drivers, and restraints of rheumatology therapeutics market. This report includes a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porters five forces model for the rheumatology therapeutics market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared by using data sourced from in-house databases, secondary and primary research team of industry experts. Research analysts and consultants cooperate with leading companies of the concerned domain to verify every value of data exists in this report.
The study provides a decisive view on the rheumatology therapeutics market by segmenting the market based on disease type, drug type, distribution channel, and region. All these segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022.
On the basis of disease type, the global rheumatology therapeutics market is divided into rheumatoid arthritis, osteoarthritis, lupus, gout, ankylosing spondylitis and other. Rheumatoid arthritis disease has high prevalence rates than other disease and accounts for the major share in global rheumatology therapeutics market. On the basis of drug type the market is segmented into non-steroidal anti-inflammatory drugs, analgesics, disease modifying anti-rheumatic drugs, corticosteroids and other. The distribution channel segment of rheumatology therapeutics includes a retail pharmacy, online pharmacy, and hospitals. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East and Africa with its further bifurcation into major countries including U.S., Germany, France, UK, China, Japan, India, and Brazil.
Some of the key players operating in the rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck Co., Inc., Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Takeda Pharmaceutical and Sanofi.
This report segments the rheumatology therapeutics market as follows:
Global Rheumatology Therapeutics Market: Disease Type Analysis
Rheumatoid Arthritis
Ankylosing spondylitis
Osteoarthritis
Lupus
Gout
Other
Global Rheumatology Therapeutics Market: Drug Type Analysis
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Analgesics
Disease Modifying Anti-Rheumatic Drugs (DMARDs)
Corticosteroids
Others
Global Rheumatology Therapeutics Market: Distribution Channel Analysis
Retail Pharmacy
Online Pharmacy
Hospitals
Other
Global Rheumatology Therapeutics Market: Regional Analysis
North America
The U.S.
Canada
Rest of North America
Europe
Germany
UK
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East Africa
Saudi Arabia
UAE
South Africa
Qatar
Rest of the Middle East and Africa
